Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) — New York, New York

Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.

Sponsors: Pierre Fabre Medicament.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center (Adults and Pediatrics)?

Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) conducted?

Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) has 1 clinical trials on record, with 1 currently active. Their work covers Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.

Is Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) accredited by Crixeo Health?

Memorial Sloan Kettering Cancer Center (Adults and Pediatrics) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center (Adults and Pediatrics)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.